FDA: Recalled catheters pose serious safety risk; compounded drug recalled
Cordis Corporation recently recalled 25,000 catheters used to visualize and measure parts of the vascular system, due to the potential for their marker bands to move or dislodge during procedures. The Food and Drug Administration has identified this as a Class I recall due to the potential for serious injury or death.
In other news, IntegraDose Compounding Services this week recalled certain lots of Cefazolin for injection, an intravenous antibiotic, due to a lack of sterility assurance. The lots were recently distributed to U.S. hospitals, which should immediately quarantine the product for return to the company.
Related News Articles
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…
Headline
The Food and Drug Administration the week of July 24 updated its recognized consensus standards database for medical devices to advance innovation in medical…
Headline
Commenting yesterday on the Environmental Protection Agency’s proposed standards for ethylene oxide use to sterilize medical devices, AHA encouraged the agency…